Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2017 by Jonsson Comprehensive Cancer Center
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01345136
First received: April 21, 2011
Last updated: April 25, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 1, 2019
  Estimated Primary Completion Date: February 1, 2018 (Final data collection date for primary outcome measure)